Earnings Whisper ®
4th Quarter December 2017
Revenue: $361.17 Mil
Guidance announcement made Thursday, October 26, 2017
Thursday, October 26, 2017
What do you expect when IART reports earnings?
Where is IART's stock price going from here?
Integra LifeSciences Corp. develops, manufactures and markets medical devices, implants and biomaterials primarily used in the treatment of burns and skin defects, spinal and cranial disorders, orthopedics and other surgical applications. Integra seeks to be the world's leading company specializing in implantable medical and biopharmaceutical therapies to target and control cell behavior, and to build shareholder value by acquiring, discovering, and developing cost-effective, off-the-shelf products that satisfy unmet medical needs.